MiMedx Group, Inc.
MDXG
$3.56
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -33.12% | 27.11% | 35.30% | 13.07% | 4.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -33.12% | 27.11% | 35.30% | 13.07% | 4.13% |
| Cost of Revenue | 4.89% | 12.69% | 22.17% | 25.76% | 27.50% |
| Gross Profit | -41.91% | 30.32% | 38.22% | 10.47% | -0.10% |
| SG&A Expenses | -11.24% | 19.62% | 27.39% | 40.37% | 8.17% |
| Depreciation & Amortization | 204.04% | -33.16% | -41.67% | -47.37% | -47.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.15% | 18.66% | 26.09% | 35.26% | 11.89% |
| Operating Income | -294.51% | 89.07% | 93.63% | -47.25% | -37.74% |
| Income Before Tax | -278.02% | 93.75% | 100.10% | -43.97% | -24.52% |
| Income Tax Expenses | -381.37% | 73.29% | 72.30% | -39.43% | -32.33% |
| Earnings from Continuing Operations | -254.63% | 104.24% | 112.59% | -45.42% | -22.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -254.63% | 104.24% | 106.89% | -45.43% | -24.17% |
| EBIT | -294.51% | 89.07% | 93.63% | -47.25% | -37.74% |
| EBITDA | -226.00% | 71.86% | 117.84% | -36.88% | -18.31% |
| EPS Basic | -253.46% | 102.77% | 105.26% | -45.57% | -24.64% |
| Normalized Basic EPS | -276.71% | 90.87% | 93.78% | -44.16% | -33.52% |
| EPS Diluted | -253.46% | 99.40% | 113.59% | -49.83% | -22.19% |
| Normalized Diluted EPS | -279.17% | 90.95% | 93.12% | -44.15% | -32.84% |
| Average Basic Shares Outstanding | 0.80% | 0.74% | 0.73% | 0.30% | 0.59% |
| Average Diluted Shares Outstanding | -0.82% | 0.63% | 0.90% | 0.28% | -0.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |